![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.430, 2003-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antisecretory use continues after H. pylori eradication in Denmark
Inpharma, Vol. 1, Iss. 1405, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Acid suppressants still used in PUD after H. pylori eradication
Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
GORD relapse may be delayed after H. pylori eradication
Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
H. pylori eradication cost effective for peptic ulcer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 310, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
H. pylori eradication improves QOL in dyspepsia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 353, 2002-01 ,pp. :